347850 — DND Pharmatech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual balance sheet for DND Pharmatech, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	PROSPECTUS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	60,612	75,958	25,504	15,642	30,014
Net Total Accounts Receivable
Net Total Receivables	149	133	438	1,521	5,672
Prepaid Expenses
Total Other Current Assets
Total Current Assets	66,544	81,692	33,355	19,565	39,794
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8,147	10,966	3,024	6,422	7,729
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	229,161	251,109	93,642	79,204	97,500
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9,141	66,859	54,923	7,487	11,115
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	48,328	119,000	84,201	32,554	27,388
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	180,833	132,109	9,440	46,650	70,112
Total Liabilities & Shareholders' Equity	229,161	251,109	93,642	79,204	97,500
Total Common Shares Outstanding